Home » Authors » Jim Stommen

Articles by Jim Stommen

McClellan sees CMS, industry partnering in innovation push

March 7, 2005

Panel: In order to avoid pitfalls, start reimbursement drive early

March 4, 2005

VivoMetrics monitors growing opportunities for LifeShirt

Jan. 6, 2005

VivoMetrics monitors growing opportunities for LifeShirt

Jan. 4, 2005

Growing convergence of technologies interests clinicians, industry

June 1, 2004

'Cautious Optimism' Replaces Gloom And Doom For Biotech

Jan. 13, 2003

'Cautious Optimism' Replaces Gloom And Doom For Biotech

Jan. 13, 2003

Innovative technologies from smaller cardio firms stir interest

March 1, 2002

It's no MIRACLE that new EP therapies are being ADOPTed

July 1, 2001

Big hitters, emerging firms tell their tales at Piper Jaffray gathering

March 1, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...